Interferon

Interferon - most related articles:

- Genetic breakthrough boosting natural immunity - 4.7
- A new drug may improve Hepatitis C - 3.7
- MS drugs help, but come at high cost - 3.4
- Combination therapy and antibiotics may help multiple sclerosis patients - 3.2
- Incivek for hepatitis C infection is approved in US - 2.9
- New therapy promising for melanoma skin cancer - 2.9
- New drug alemtuzumab for multiple sclerosis patients - 2.8
- HIV progresses faster in women than in men - 2.8
- Researchers discover TRIM22 gene that blocks HIV - 2

Interferon articles

Incivek for hepatitis C infection is approved in US
The U.S. Food and Drug Administration approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies.

Early detection of skin cancer melanoma is vital
On television's popular "Grey's Anatomy," Dr. Izzie Stevens faces a grim diagnosis: stage IV metastatic melanoma. As the drama unfolds, viewers get a glimpse at why patients with the deadliest form of skin cancer – in the most advanced stage of diagnosis – face a mere 10-month median survival rate.

Positive results of Albuferon in Chronic Hepatitis C
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that Albuferon (albinterferon alfa-2b) met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) in ACHIEVE 1, a Phase 3 clinical trial of Albuferon in combination with ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C (p=0.0008).

Hepatitis C declines health with liver disease
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.

New therapy promising for melanoma skin cancer
The combination of two different biotherapies (interferon alfa-2b and tremelimumab) may be beneficial for patients with inoperable melanoma, revealed by researchers in US.

Genetic breakthrough boosting natural immunity
Researchers at McGill University have discovered a way to boost an organism's natural anti-virus defences, effectively making its cells immune to influenza and other viruses.

6 Interferon articles listed above.


Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
2.77